clinical hold

FDA stop sign
Biotech

FDA hits Kezar's zetomipzomib with 2nd clinical hold in 2 months

The FDA has placed a partial hold on the PORTOLA trial evaluating the selective immunoproteasome inhibitor in 24 patients with autoimmune hepatitis.
James Waldron Nov 13, 2024 5:22am
FDA stop sign

Rapt's share price sinks after shelving AD drug under FDA hold

Nov 11, 2024 9:44am
FDA stop sign

FDA places Rapport's nerve damage trial on hold

Nov 7, 2024 8:50am
yellow traffic light

FDA puts partial hold on BioNTech-OncoC4 phase 3 trial

Oct 18, 2024 12:55pm
Novavax

FDA puts Novavax's phase 3 plan on hold for pair of vaccines

Oct 16, 2024 9:10am
FDA stop sign

FDA places Kezar lupus trial in hold following 4 patient deaths

Oct 7, 2024 5:50am